NewEdge Advisors LLC Purchases 41,950 Shares of Merck & Co., Inc. $MRK
MarketBeat
NewEdge Advisors LLC increased its stake in Merck & Co., Inc. by 10.1% in the second quarter, adding 41,950 shares to now own 455,515 shares valued at $58.5 million. Institutional investors collectively own 76.07% of Merck's stock. Despite positive analyst ratings and strong revenue growth, the company faces challenges including the impending patent expiration of Keytruda in 2028 and past weaknesses in Gardasil sales.
Read the full story
This is a short summary. The complete article is published by MarketBeat.
Headline and summary aggregated from public news feeds. For information only — not financial advice.